Czechia· CZ-0238422
AJOVY
A fremanezumab product containing fremanezumab, registered in Czechia by Teva GmbH, Ulm. The same ATC class is registered in 15 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Fremanezumab is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CD03 (fremanezumab), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Fremanezumab · ATC N02CD03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FREMANEZUMAB
- Manufacturer
- Teva GmbH, Ulm
- Country
- Czechia (CZ)
- ATC code
- N02CD03
- ATC class
- Fremanezumab
- Defined daily dose
- 7.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02384221X1,5MLCZK 10134.79
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fremanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAJOVY 225 mg Injektionsvätska, lösning i förfylld injektionspennaTEVA GmbH
- NorwayAjovyTeva GmbH
- BelgiumAjovy 225 mgTeva
- SpainAJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATeva Gmbh
- IcelandAJOVYTEVA GmbH
- SwitzerlandAJOVY 225 mg, Injektionslösung im FertigpenTeva Pharma AG
- PolandAjovyTEVA GmbH
- United StatesAJOVYTeva Pharmaceuticals USA, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Ajovy
- Iceland · Ajovy
- Liechtenstein · Ajovy
- Norway · Ajovy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08360107-d628-4e3b-8d22-b6ff43d62dec GET /v1/drugs/08360107-d628-4e3b-8d22-b6ff43d62dec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL ISP",
"source": "sukl",
"strength": "225MG",
"pack_size": "1X1,5ML",
"substance": "FREMANEZUMAB",
"cz_kod_sukl": "0238422",
"product_type": "BT",
"substance_codes": "21150",
"registration_state": "R",
"registration_number": "EU/1/19/1358/001"
}See everything about fremanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.